DANIEL AYANGA

Concepts (11)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Opiate Substitution Treatment
1
2016
35
0.540
Why?
Adrenergic alpha-2 Receptor Agonists
1
2016
35
0.540
Why?
Narcotic Antagonists
1
2016
155
0.510
Why?
Buprenorphine
1
2016
106
0.500
Why?
Opioid-Related Disorders
1
2016
419
0.380
Why?
Clonidine
1
2016
66
0.140
Why?
Naltrexone
1
2016
99
0.130
Why?
Methadone
1
2016
214
0.120
Why?
Combined Modality Therapy
1
2016
9039
0.060
Why?
Treatment Outcome
1
2016
33737
0.030
Why?
Humans
1
2016
270740
0.010
Why?
AYANGA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (11)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_